Cadrenal Therapeutics Inc (CVKD) Stock Price, Quote, News & History

CVKDNASDAQ
$2.16
-0.17-7.30%
At close: Jul 17, 5:00 PM EST
$2.10
-0.06-2.78%
After Hours: Jul 17, 7:59 PM EST

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-10.96M
Investing Cash Flow (TTM)
-1.85K
Financing Cash Flow (TTM)
5.93M
Free Cash Flow (TTM)
-10.96M
Capital Expenditure (TTM)
-
Net Change in Cash (TTM)
-5.03M

Analyst Trends and Forecast

1
Apr
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
4.3
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$2.30M
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
-
PB Ratio (TTM)
4.02
Earnings Yield % (TTM)
-239.91%
Earnings Yield % (FWD)
-206.87%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$0.58

Company Debt

Total Debt
-
LT Debt
-
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-
Total Cash
$2.31M
Debt to Equity
-
Issuance of Debt (TTM)
-
Repayment of Debt (TTM)
-

Key Statistics

Open
$2.30
Close
$2.16
Volume / Avg.
46.68K / 78.69K
Day Range
$2.13 - $2.36
52 Wk Range
2.29 - 14.64
Market Cap
$6.51M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
27
Short Interest
3.11%
Days to Cover
1.21

About

Sector
Health Care
Industry
Pharmaceuticals
Cadrenal Therapeutics Inc is a late-stage biopharmaceutical company advancing novel therapies for life-threatening immune and thrombotic conditions. Its product candidate, CAD-1005, is a first-in-class selective 12-LOX inhibitor being developed to tr...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Cadrenal Therapeutics (CVKD) stock?

A

You can purchase shares of Cadrenal Therapeutics (NASDAQ:CVKD) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Cadrenal Therapeutics (CVKD) competitors?

A

There are no as such competitors for Cadrenal Therapeutics.

Q

What is the forecast, or price target, for Cadrenal Therapeutics (CVKD) stock?

A

Cadrenal Therapeutics has a consensus price target of $8.50.

Q

What is the current price for Cadrenal Therapeutics (CVKD)?

A

The stock price for Cadrenal Therapeutics (NASDAQ: CVKD) is $2.1 last updated July 17, 2026 at 7:59 PM EDT.

Q

Does Cadrenal Therapeutics (CVKD) pay a dividend?

A

There are no upcoming dividends for Cadrenal Therapeutics.

Q

When is Cadrenal Therapeutics (NASDAQ:CVKD) reporting earnings?

A

Cadrenal Therapeutics does not have any upcoming earnings scheduled.

Q

Is Cadrenal Therapeutics (CVKD) going to split?

A

There is no upcoming split for Cadrenal Therapeutics.

Q

What sector and industry does Cadrenal Therapeutics (CVKD) operate in?

A

Cadrenal Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.